These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15952604)

  • 1. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
    Adesunloye TA; Stach PE
    Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
    J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of formaldehyde-induced crosslinking in soft elastic gelatin capsules using near-infrared spectrophotometry.
    Gold TB; Buice RG; Lodder RA; Digenis GA
    Pharm Dev Technol; 1998 May; 3(2):209-14. PubMed ID: 9653758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
    Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
    Likar MD; Carroll SC; Colgan ST; Yeoh T; MacDonald BC; Johnson GM; Space JS
    J Pharm Sci; 2018 Dec; 107(12):3080-3088. PubMed ID: 30145210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheres.
    Vandelli MA; Forni F; Iannuccelli V; Cameroni R
    J Pharm Belg; 1991; 46(6):381-8. PubMed ID: 1783972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
    Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK
    J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting zero-order release kinetics of porous gelatin capsules.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Jun; 24(6):557-62. PubMed ID: 9876623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of gelatin by reaction with 1,6-diisocyanatohexane.
    Bertoldo M; Bronco S; Gragnoli T; Ciardelli F
    Macromol Biosci; 2007 Mar; 7(3):328-38. PubMed ID: 17370271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaradehyde.
    Yong CS; Li DX; Oh DH; Kim JA; Yoo BK; Woo JS; Rhee JD; Choi HG
    Arch Pharm Res; 2006 Jun; 29(6):520-4. PubMed ID: 16833022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraoralia containing gelatin--a dissolution model and means of influencing dissolution behavior].
    Voigt R; Werchan D
    Pharmazie; 1986 Jan; 41(1):33-8. PubMed ID: 3960946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution rate of chloramphenicol from hard gelatin capsules as a function of type of adjuvants and method of granulation.
    Abd Elbary A; Fadel HM; Nour SA
    Pharmazie; 1984 Feb; 39(2):110-2. PubMed ID: 6718476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of extent of formaldehyde-induced crosslinking in hard gelatin capsules by near-infrared spectrophotometry.
    Gold TB; Buice RG; Lodder RA; Digenis GA
    Pharm Res; 1997 Aug; 14(8):1046-50. PubMed ID: 9279887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D; Bindra DS
    Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel bone substitute composed of oligomeric proanthocyanidins-crosslinked gelatin and tricalcium phosphate.
    Chen KY; Shyu PC; Chen YS; Yao CH
    Macromol Biosci; 2008 Oct; 8(10):942-50. PubMed ID: 18555459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-free quinone crosslinking reaction for proteins: a macromolecular characterization study using gelatin.
    Yamauchi A; Hatanaka Y; Muro T; Kobayashi O
    Macromol Biosci; 2009 Sep; 9(9):875-83. PubMed ID: 19434678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosslinked gelatin matrices: release of a random coil macromolecular solute.
    Mwangi JW; Ofner CM
    Int J Pharm; 2004 Jul; 278(2):319-27. PubMed ID: 15196637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the temporal change of properties of genipin crosslinked gelatin].
    Jin X; Yan J; Zhou L; Ji Y; Yang X; Xu G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):150-3. PubMed ID: 18435279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.